Skip to main content
SpringerLink
Log in

Comparative safety of ICS/LABA fixed combinations

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. EUPAS12330

Reference

  • Price DB, et al. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta-2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care. Drugs : 20 Nov 2019. Available from: URL: http://doi.org/10.1007/s40265-019-01224-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Comparative safety of ICS/LABA fixed combinations. Reactions Weekly 1782, 8 (2019). https://doi.org/10.1007/s40278-019-72177-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72177-x

Search

Navigation